Health Canada drug identification number

DIN 02507366 — DAYVIGO 5 MG

DAYVIGO is a tablet of Lemborexant marketed by EISAI LIMITED. The full Lemborexant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02507366
Brand name
DAYVIGO
Active ingredient
Lemborexant
Strength
5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
EISAI LIMITED
Health Canada status
MARKETED
Drug class
Dual orexin receptor antagonist (hypnotic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Lemborexant products

DINBrandStrengthFormManufacturerStatus
02507374 DAYVIGO 10 MG TABLET EISAI LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.